These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

262 related articles for article (PubMed ID: 3296437)

  • 1. [Immunity and immunosuppression in tumor growth].
    Govallo VI
    Vopr Onkol; 1987; 33(4):91-9. PubMed ID: 3296437
    [No Abstract]   [Full Text] [Related]  

  • 2. Natural killer cells and tumor immunity: 1987.
    Hiserodt JC; Herberman RB
    Year Immunol; 1989; 4():201-7. PubMed ID: 2648702
    [No Abstract]   [Full Text] [Related]  

  • 3. Contrasuppression, tolerance, and tumor immunity.
    Green DR; Friedman A; Ptak W; McGhee J; Flood PM
    Prog Clin Biol Res; 1989; 288():245-58. PubMed ID: 2566175
    [No Abstract]   [Full Text] [Related]  

  • 4. [Immunological properties of tumor cells that determine the degree of their malignancy].
    Lavrovskiĭ VA; Viksler VKh
    Usp Sovrem Biol; 1981; 91(2):228-40. PubMed ID: 7018110
    [No Abstract]   [Full Text] [Related]  

  • 5. NKT cells and tumor immunity--a double-edged sword.
    Smyth MJ; Godfrey DI
    Nat Immunol; 2000 Dec; 1(6):459-60. PubMed ID: 11101862
    [No Abstract]   [Full Text] [Related]  

  • 6. Tumor-infiltrating lymphocytes: evidence for specific immune reactions against growing cancers in mice and humans.
    Topalian SL; Rosenberg SA
    Important Adv Oncol; 1990; ():19-41. PubMed ID: 2182519
    [No Abstract]   [Full Text] [Related]  

  • 7. [Antitumoral action of interferons and interleukins in combination with radiotherapy. Part I: immunologic basis].
    Herskind C; Fleckenstein K; Lohr J; Li CY; Wenz F; Lohr F
    Strahlenther Onkol; 2004 Apr; 180(4):187-93. PubMed ID: 15057428
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The preclinical screening laboratory: evaluation of immunomodulatory and therapeutic properties of biological response modifiers.
    Talmadge JE; Herberman RB
    Cancer Treat Rep; 1986 Jan; 70(1):171-82. PubMed ID: 3510733
    [No Abstract]   [Full Text] [Related]  

  • 9. Immunoregulatory T cells in tumor immunity.
    Terabe M; Berzofsky JA
    Curr Opin Immunol; 2004 Apr; 16(2):157-62. PubMed ID: 15023407
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Immunology. Stress, NK receptors, and immune surveillance.
    Pardoll DM
    Science; 2001 Oct; 294(5542):534-6. PubMed ID: 11567108
    [No Abstract]   [Full Text] [Related]  

  • 11. Innate immune recognition and suppression of tumors.
    Hayakawa Y; Smyth MJ
    Adv Cancer Res; 2006; 95():293-322. PubMed ID: 16860661
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Analyses and perspectives in cancer immunotherapy.
    Nguyen van Binh P; Duc HT
    Biomed Pharmacother; 2006 Nov; 60(9):621-8. PubMed ID: 16978826
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Natural killer cells and their possible roles in host resistance against tumors.
    Herberman RB
    Transplant Proc; 1984 Apr; 16(2):476-8. PubMed ID: 6719548
    [No Abstract]   [Full Text] [Related]  

  • 14. Immunologic aspects of malignant tumors.
    Ariyan S
    Clin Plast Surg; 1979 Apr; 6(2):125-142. PubMed ID: 313868
    [No Abstract]   [Full Text] [Related]  

  • 15. Functions of natural killer cells.
    Vivier E; Tomasello E; Baratin M; Walzer T; Ugolini S
    Nat Immunol; 2008 May; 9(5):503-10. PubMed ID: 18425107
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Exploiting dendritic cells and natural killer T cells in immunotherapy against malignancies.
    Fujii S
    Trends Immunol; 2008 May; 29(5):242-9. PubMed ID: 18372215
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Immunotherapy of established tumors in mice by intratumoral injection of an adenovirus vector harboring the human IL-2 cDNA: induction of CD8(+) T-cell immunity and NK activity.
    Slos P; De Meyer M; Leroy P; Rousseau C; Acres B
    Cancer Gene Ther; 2001 May; 8(5):321-32. PubMed ID: 11477452
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Immunological abnormality in malignant neoplasms].
    Tsubura E; Yamashita Y; Yagi M
    Nihon Rinsho; 1981 Apr; 39(4):1772-7. PubMed ID: 6458709
    [No Abstract]   [Full Text] [Related]  

  • 19. [Protein deficiency, host defense and natural anti-tumor immunity].
    Ruffmann R; Schlick E; Tartaris T; Chirigos MA
    Infusionsther Klin Ernahr; 1986 Apr; 13(2):106-12. PubMed ID: 3519454
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Inhibition of T cell and natural killer cell function by adenosine and its contribution to immune evasion by tumor cells (Review).
    Hoskin DW; Mader JS; Furlong SJ; Conrad DM; Blay J
    Int J Oncol; 2008 Mar; 32(3):527-35. PubMed ID: 18292929
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.